The clinical performance is complex and often involves multiple systemic burdens. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of IBD requires a combination of clinical performance, imaging inspection, laboratory testing and pathological evaluation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of IBD with prognosis require individualized treatment, usually including drug therapy, rehabilitation, regular follow-up, and other multidimensional management of the colon. In recent years, with the development of treatment-oriented, immune-regulatory treatment and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions, adapting to timely schemes based on changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of IBD-associated colon expansion. The platform serves a team of domestic and foreign experts in the field of respiratory digestive endocrine disorders in China, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.